Abstract
The article presents brief data from the literature about the history of BCG vaccine development (Bacille bilie' Calmette-Gue'rin), results of meta-analyses aimed at the evaluation of BCG-therapy efficiency in Ta-T1 bladder cancer. Below one can read descriptions of clinical cases when side effects and complications of this method developed according to the literature data and results of authors' personal observations. The main reason of low level of BCG-therapy use in Russia is low awareness of medical workers about the legal grounds for application of this method. The article gives the list of acting legal acts regulating provision of epidemiological safety when applying BCG-therapy and describes the technique for using this method in municipal polyclinics in compliance with the above legal acts.
Highlights
The article presents brief data from the literature about the history of bilie' Calmette-Gue'rin (BCG) vaccine development (Bacille bilie' Calm ette-G ue'rin), results of m eta-analyses aimed at the evaluation of B C G -therapy efficiency in Ta-T1 bladder cancer
One can read descriptions of clinical cases w hen side effects and com plications of this m ethod developed according to the literature d ata and results of authors' personal observations
The article gives the list of acting legal acts regulating provision of epidemiological safety when applying B C G -therapy and describes the technique for using this m ethod in municipal polyclinics in compliance w ith the above legal acts
Summary
The article presents brief data from the literature about the history of BCG vaccine development (Bacille bilie' Calm ette-G ue'rin), results of m eta-analyses aimed at the evaluation of B C G -therapy efficiency in Ta-T1 bladder cancer. Описан случай развития туберкулеза полового члена после BCG-терапии. Известно несколько случаев развития милиарного туберкулеза после еженедельных инстилляций вакцины BCG.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.